The frequency of gastrointestinal side effects is higher with retatrutide (nausea affects about 43% vs 12-33% for Mounjaro)
If you maintain both an HSA and FSA simultaneously, federal rules require you to use the HSA exclusively for medical expensesyou cannot claim the same expense twice
Retatrutide and tirzepatide both support weight loss by helping regulate appetite and improving metabolic function
Weight loss is now the primary motivation, surpassing diabetes management
First, the pipeline management decisions manufacturers make now which lifecycle management investments to fund, which reformulations to patent will produce returns in a market five to seven years from now when Cost Plus will be significantly larger and more embedded in employer benefit designs
Semaglutide is administered via subcutaneous injection and has shown significant benefits in weight loss in clinical trials, leading to its approval for obesity treatment as well